Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy to lymph nodes in oligoprogressive castration-resistant prostate cancer patients: a post hoc analysis from two phase I clinical trials

Published:2021-10-15 Issue:6 Volume:38 Page:519-526
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Pezzulla D.,Macchia G.^ORCID,Cilla S.,Buwenge M.,Ferro M.,Bonome P.,Romano C.,Zamagni A.,Valentini V.,Morganti A. G.,Deodato F.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10585-021-10126-7.pdf

Reference33 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209

2. Hansen EK, Roach M (2018) Handbook of evidence-based radiation oncology. Springer, Cham

3. NCCN Guidelines Version 2.2021 Prostate Cancer. https://www.nccn.org/professionals/physician_gls/pdf/prostate_blocks.pdf. Accessed 19 Mar 2021

4. EAU. Guidelines: prostate cancer uroweb. https://uroweb.org/guideline/prostate-cancer/. Accessed 19 Mar 2021

5. Siva S, Bressel M, Murphy DG et al (2018) Stereotactic abative body radiotherapy (SABR) for oligometastatic prostate cancer: a prospective clinical trial. Eur Urol 74:455–462

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-11

2. Is Local Ablative Stereotactic Radiation Therapy a Valuable Rescue Strategy for Time on Drug in Patients Enrolled in Phase I Trials?;International Journal of Radiation Oncology*Biology*Physics;2024-08

3. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer;Radiotherapy and Oncology;2024-07

4. The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer;Prostate Cancer and Prostatic Diseases;2024-06-19

5. SBRT in Lymph-Nodal Oligometastases from Prostate Cancer: Different Outcomes between Pelvic and Para-Aortic Disease;Journal of Clinical Medicine;2024-06-03